The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Bioplastic Market Research Report 2025
Synopsis
Medical bioplastics are a type of plastic material that is derived from renewable sources and designed to be biocompatible and environmentally friendly. These bioplastics have applications in the medical and healthcare industry due to their potential benefits in reducing waste, minimizing environmental impact, and promoting better patient outcomes.
Global Medical Bioplastic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Bioplastic market research.
The global medical bioplastics market has been experiencing steady growth in recent years. The increasing demand for sustainable and environmentally friendly materials in the healthcare sector, coupled with the growing awareness of plastic waste reduction, has been driving market expansion. Medical bioplastics have a wide range of applications in the healthcare industry, including surgical instruments, implantable devices, drug delivery systems, wound care products, orthopedic implants, and disposable medical supplies. The market growth is fueled by the demand for biocompatible, lightweight, and customizable materials that offer improved performance in medical devices.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Bioplastic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF
Mitsubishi Chemical
Eastman
Futamura Group
Neste
TotalEnergies Corbion
NatureWorks
DSM
Braskem
Corbion
Evonik
Bormioli Pharma
Biome Bioplastics
Novamont
Segment by Type
Bio-PE
Regenerated Cellulose
Poly Hydroxyalkonoates
Polylactic Acid (PLA)
Others
Segment by Application
Wound Management
Drug Delivery
Orthopedic Instruments
Fiber And Porous Scaffolds
Pharmaceutical Packaging
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Medical Bioplastic report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Medical bioplastics are a type of plastic material that is derived from renewable sources and designed to be biocompatible and environmentally friendly. These bioplastics have applications in the medical and healthcare industry due to their potential benefits in reducing waste, minimizing environmental impact, and promoting better patient outcomes.
Global Medical Bioplastic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Bioplastic market research.
The global medical bioplastics market has been experiencing steady growth in recent years. The increasing demand for sustainable and environmentally friendly materials in the healthcare sector, coupled with the growing awareness of plastic waste reduction, has been driving market expansion. Medical bioplastics have a wide range of applications in the healthcare industry, including surgical instruments, implantable devices, drug delivery systems, wound care products, orthopedic implants, and disposable medical supplies. The market growth is fueled by the demand for biocompatible, lightweight, and customizable materials that offer improved performance in medical devices.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Bioplastic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF
Mitsubishi Chemical
Eastman
Futamura Group
Neste
TotalEnergies Corbion
NatureWorks
DSM
Braskem
Corbion
Evonik
Bormioli Pharma
Biome Bioplastics
Novamont
Segment by Type
Bio-PE
Regenerated Cellulose
Poly Hydroxyalkonoates
Polylactic Acid (PLA)
Others
Segment by Application
Wound Management
Drug Delivery
Orthopedic Instruments
Fiber And Porous Scaffolds
Pharmaceutical Packaging
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Medical Bioplastic report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Medical Bioplastic Market Overview
1.1 Product Definition
1.2 Medical Bioplastic Segment by Type
1.2.1 Global Medical Bioplastic Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Bio-PE
1.2.3 Regenerated Cellulose
1.2.4 Poly Hydroxyalkonoates
1.2.5 Polylactic Acid (PLA)
1.2.6 Others
1.3 Medical Bioplastic Segment by Application
1.3.1 Global Medical Bioplastic Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Wound Management
1.3.3 Drug Delivery
1.3.4 Orthopedic Instruments
1.3.5 Fiber And Porous Scaffolds
1.3.6 Pharmaceutical Packaging
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Medical Bioplastic Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Medical Bioplastic Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Medical Bioplastic Production Estimates and Forecasts (2018-2029)
1.4.4 Global Medical Bioplastic Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Medical Bioplastic Production Market Share by Manufacturers (2018-2023)
2.2 Global Medical Bioplastic Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Medical Bioplastic, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Medical Bioplastic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Medical Bioplastic Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Medical Bioplastic, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medical Bioplastic, Product Offered and Application
2.8 Global Key Manufacturers of Medical Bioplastic, Date of Enter into This Industry
2.9 Medical Bioplastic Market Competitive Situation and Trends
2.9.1 Medical Bioplastic Market Concentration Rate
2.9.2 Global 5 and 10 Largest Medical Bioplastic Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medical Bioplastic Production by Region
3.1 Global Medical Bioplastic Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Medical Bioplastic Production Value by Region (2018-2029)
3.2.1 Global Medical Bioplastic Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Medical Bioplastic by Region (2024-2029)
3.3 Global Medical Bioplastic Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Medical Bioplastic Production by Region (2018-2029)
3.4.1 Global Medical Bioplastic Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Medical Bioplastic by Region (2024-2029)
3.5 Global Medical Bioplastic Market Price Analysis by Region (2018-2023)
3.6 Global Medical Bioplastic Production and Value, Year-over-Year Growth
3.6.1 North America Medical Bioplastic Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Medical Bioplastic Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Medical Bioplastic Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Medical Bioplastic Production Value Estimates and Forecasts (2018-2029)
4 Medical Bioplastic Consumption by Region
4.1 Global Medical Bioplastic Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Medical Bioplastic Consumption by Region (2018-2029)
4.2.1 Global Medical Bioplastic Consumption by Region (2018-2023)
4.2.2 Global Medical Bioplastic Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Medical Bioplastic Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Medical Bioplastic Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medical Bioplastic Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Medical Bioplastic Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medical Bioplastic Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Medical Bioplastic Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medical Bioplastic Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Medical Bioplastic Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Medical Bioplastic Production by Type (2018-2029)
5.1.1 Global Medical Bioplastic Production by Type (2018-2023)
5.1.2 Global Medical Bioplastic Production by Type (2024-2029)
5.1.3 Global Medical Bioplastic Production Market Share by Type (2018-2029)
5.2 Global Medical Bioplastic Production Value by Type (2018-2029)
5.2.1 Global Medical Bioplastic Production Value by Type (2018-2023)
5.2.2 Global Medical Bioplastic Production Value by Type (2024-2029)
5.2.3 Global Medical Bioplastic Production Value Market Share by Type (2018-2029)
5.3 Global Medical Bioplastic Price by Type (2018-2029)
6 Segment by Application
6.1 Global Medical Bioplastic Production by Application (2018-2029)
6.1.1 Global Medical Bioplastic Production by Application (2018-2023)
6.1.2 Global Medical Bioplastic Production by Application (2024-2029)
6.1.3 Global Medical Bioplastic Production Market Share by Application (2018-2029)
6.2 Global Medical Bioplastic Production Value by Application (2018-2029)
6.2.1 Global Medical Bioplastic Production Value by Application (2018-2023)
6.2.2 Global Medical Bioplastic Production Value by Application (2024-2029)
6.2.3 Global Medical Bioplastic Production Value Market Share by Application (2018-2029)
6.3 Global Medical Bioplastic Price by Application (2018-2029)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Medical Bioplastic Corporation Information
7.1.2 BASF Medical Bioplastic Product Portfolio
7.1.3 BASF Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.1.4 BASF Main Business and Markets Served
7.1.5 BASF Recent Developments/Updates
7.2 Mitsubishi Chemical
7.2.1 Mitsubishi Chemical Medical Bioplastic Corporation Information
7.2.2 Mitsubishi Chemical Medical Bioplastic Product Portfolio
7.2.3 Mitsubishi Chemical Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Mitsubishi Chemical Main Business and Markets Served
7.2.5 Mitsubishi Chemical Recent Developments/Updates
7.3 Eastman
7.3.1 Eastman Medical Bioplastic Corporation Information
7.3.2 Eastman Medical Bioplastic Product Portfolio
7.3.3 Eastman Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Eastman Main Business and Markets Served
7.3.5 Eastman Recent Developments/Updates
7.4 Futamura Group
7.4.1 Futamura Group Medical Bioplastic Corporation Information
7.4.2 Futamura Group Medical Bioplastic Product Portfolio
7.4.3 Futamura Group Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Futamura Group Main Business and Markets Served
7.4.5 Futamura Group Recent Developments/Updates
7.5 Neste
7.5.1 Neste Medical Bioplastic Corporation Information
7.5.2 Neste Medical Bioplastic Product Portfolio
7.5.3 Neste Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Neste Main Business and Markets Served
7.5.5 Neste Recent Developments/Updates
7.6 TotalEnergies Corbion
7.6.1 TotalEnergies Corbion Medical Bioplastic Corporation Information
7.6.2 TotalEnergies Corbion Medical Bioplastic Product Portfolio
7.6.3 TotalEnergies Corbion Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.6.4 TotalEnergies Corbion Main Business and Markets Served
7.6.5 TotalEnergies Corbion Recent Developments/Updates
7.7 NatureWorks
7.7.1 NatureWorks Medical Bioplastic Corporation Information
7.7.2 NatureWorks Medical Bioplastic Product Portfolio
7.7.3 NatureWorks Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.7.4 NatureWorks Main Business and Markets Served
7.7.5 NatureWorks Recent Developments/Updates
7.8 DSM
7.8.1 DSM Medical Bioplastic Corporation Information
7.8.2 DSM Medical Bioplastic Product Portfolio
7.8.3 DSM Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.8.4 DSM Main Business and Markets Served
7.7.5 DSM Recent Developments/Updates
7.9 Braskem
7.9.1 Braskem Medical Bioplastic Corporation Information
7.9.2 Braskem Medical Bioplastic Product Portfolio
7.9.3 Braskem Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Braskem Main Business and Markets Served
7.9.5 Braskem Recent Developments/Updates
7.10 Corbion
7.10.1 Corbion Medical Bioplastic Corporation Information
7.10.2 Corbion Medical Bioplastic Product Portfolio
7.10.3 Corbion Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Corbion Main Business and Markets Served
7.10.5 Corbion Recent Developments/Updates
7.11 Evonik
7.11.1 Evonik Medical Bioplastic Corporation Information
7.11.2 Evonik Medical Bioplastic Product Portfolio
7.11.3 Evonik Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Evonik Main Business and Markets Served
7.11.5 Evonik Recent Developments/Updates
7.12 Bormioli Pharma
7.12.1 Bormioli Pharma Medical Bioplastic Corporation Information
7.12.2 Bormioli Pharma Medical Bioplastic Product Portfolio
7.12.3 Bormioli Pharma Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Bormioli Pharma Main Business and Markets Served
7.12.5 Bormioli Pharma Recent Developments/Updates
7.13 Biome Bioplastics
7.13.1 Biome Bioplastics Medical Bioplastic Corporation Information
7.13.2 Biome Bioplastics Medical Bioplastic Product Portfolio
7.13.3 Biome Bioplastics Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Biome Bioplastics Main Business and Markets Served
7.13.5 Biome Bioplastics Recent Developments/Updates
7.14 Novamont
7.14.1 Novamont Medical Bioplastic Corporation Information
7.14.2 Novamont Medical Bioplastic Product Portfolio
7.14.3 Novamont Medical Bioplastic Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Novamont Main Business and Markets Served
7.14.5 Novamont Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medical Bioplastic Industry Chain Analysis
8.2 Medical Bioplastic Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medical Bioplastic Production Mode & Process
8.4 Medical Bioplastic Sales and Marketing
8.4.1 Medical Bioplastic Sales Channels
8.4.2 Medical Bioplastic Distributors
8.5 Medical Bioplastic Customers
9 Medical Bioplastic Market Dynamics
9.1 Medical Bioplastic Industry Trends
9.2 Medical Bioplastic Market Drivers
9.3 Medical Bioplastic Market Challenges
9.4 Medical Bioplastic Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
